RS49901B - Postupak za dobijanje 2-aril-3-aril-5-halogeno piridina korisnih kao cox-2 inhibitori - Google Patents

Postupak za dobijanje 2-aril-3-aril-5-halogeno piridina korisnih kao cox-2 inhibitori

Info

Publication number
RS49901B
RS49901B YUP-536/99A YU53699A RS49901B RS 49901 B RS49901 B RS 49901B YU 53699 A YU53699 A YU 53699A RS 49901 B RS49901 B RS 49901B
Authority
RS
Serbia
Prior art keywords
aryl
pyrldines
cox
halo
inhibitors
Prior art date
Application number
YUP-536/99A
Other languages
English (en)
Inventor
Philip Pye
Ashok MALIAKAL
Kai Rossen
Ralph VOLANTE
Jess SAGER
Original Assignee
Merck & Co. Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9709686.1A external-priority patent/GB9709686D0/en
Application filed by Merck & Co. Inc., filed Critical Merck & Co. Inc.,
Publication of YU53699A publication Critical patent/YU53699A/sh
Publication of RS49901B publication Critical patent/RS49901B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00Formation or introduction of functional groups containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/52Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Postupak za dobijanje jedinjenja formule I R1 je izabrano iz grupe koju čine (a) CH3, (b) NH2, (c) NHC(O)CF3, (d) NHCH3; Ar je mono-, di- ili trisupstituisani fenil ili piridinil (ili njegov N-oksid), gde su suspstituenti izabrani iz grupe koju čine (a) vodonik, (b) halogen, (c) C1-4alkoksi, (d) C1-4alkiltio, (e) CN, (f) C1-4alkil, (g) C1-4fluoroalkil, R2 je izabrano iz grupe koju čine (a) F, Cl, Br, I (b) CN, (c) azid, naznačen time što obuhvata: kondenzacijuje dinjenja formule Al pod kiselim uslovima, i izborno u prisustvu ne-reaktivnog rastvarača i u prisustvu amonijačnog reagensa, sa jedinjenjem A2 pri čemu se dobija jedinjenje formule I.
YUP-536/99A 1997-04-18 1998-04-14 Postupak za dobijanje 2-aril-3-aril-5-halogeno piridina korisnih kao cox-2 inhibitori RS49901B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4564297P 1997-04-18 1997-04-18
GBGB9709686.1A GB9709686D0 (en) 1997-05-13 1997-05-13 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors

Publications (2)

Publication Number Publication Date
YU53699A YU53699A (sh) 2001-12-26
RS49901B true RS49901B (sr) 2008-08-07

Family

ID=26311530

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-536/99A RS49901B (sr) 1997-04-18 1998-04-14 Postupak za dobijanje 2-aril-3-aril-5-halogeno piridina korisnih kao cox-2 inhibitori

Country Status (22)

Country Link
EP (1) EP0975596B1 (sr)
JP (1) JP3300369B2 (sr)
KR (1) KR20010006546A (sr)
CN (1) CN1182117C (sr)
AT (1) ATE270275T1 (sr)
AU (1) AU729730B2 (sr)
BR (1) BR9808923B1 (sr)
CA (1) CA2287482C (sr)
CZ (1) CZ293246B6 (sr)
DE (1) DE69824839T2 (sr)
EA (1) EA002190B1 (sr)
ES (1) ES2223128T3 (sr)
HK (1) HK1023771A1 (sr)
HR (1) HRP980206B1 (sr)
HU (1) HU226999B1 (sr)
NZ (1) NZ500390A (sr)
PL (1) PL190265B1 (sr)
RS (1) RS49901B (sr)
SK (1) SK285037B6 (sr)
TW (1) TW492959B (sr)
UA (1) UA66792C2 (sr)
WO (1) WO1998047871A1 (sr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000042014A2 (de) * 1999-01-14 2000-07-20 Lonza Ag 1-(6-methylpyridin-3-yl)-2-((4-(methylsulfonyl)phenyl)ethanon und verfahren zu seiner herstellung
KR100446324B1 (ko) * 1999-01-14 2004-08-30 론자 아게 1-(6-메틸피리딘-3-일)-2-[4-(메틸술포닐)페닐]에타논 및이의 제조 방법
WO2001007410A1 (en) * 1999-07-27 2001-02-01 Lonza Ag Process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl) phenyl] ethanone
US6566527B1 (en) 1999-07-27 2003-05-20 Merck & Co., Inc. Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-methylsulphonyl)-phenyl]ethanone
EP1246621A4 (en) 1999-12-23 2004-11-24 Nitromed Inc NITROSED AND NITROSYLATED CYCLOOXYGENASE-2 INHIBITORS, COMPOSITIONS AND METHODS FOR THEIR USE
JP2001261647A (ja) * 2000-03-22 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の製造方法
PT1303265E (pt) 2000-07-20 2007-10-09 Lauras As ''utilização de inibidores da cox-2 como imuno-estimulantes, no tratamento do vih ou da sida''
EP2582690B1 (en) * 2010-06-16 2018-07-25 Glenmark Generics Limited Process for preparation of 2, 3-diaryl-5-substituted pyridines and their intermediates
CA2817939A1 (en) * 2010-11-15 2012-05-24 Virdev Intermediates Pvt. Ltd. A process for cyclooxygenase-2 selective inhibitor
CN103204803A (zh) 2012-01-13 2013-07-17 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 用于合成依托考昔的方法
WO2014114352A1 (en) * 2013-01-25 2014-07-31 Synthon Bv Process for making etoricoxib
WO2015036550A1 (en) 2013-09-13 2015-03-19 Synthon B.V. Process for making etoricoxib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH561717A5 (sr) * 1971-05-10 1975-05-15 Ciba Geigy Ag
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation
RU2200158C2 (ru) * 1995-02-13 2003-03-10 Джи.Ди.Сирл энд Ко. Замещенные изоксазолы, фармацевтические композиции на их основе и способ подавления воспалений
US5643933A (en) * 1995-06-02 1997-07-01 G. D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5677318A (en) * 1996-07-11 1997-10-14 Merck Frosst Canada, Inc. Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents
SK283261B6 (sk) * 1996-07-18 2003-04-01 Merck Frosst Canada & Co. / Merck Frosst Canada & Cie. Substituované pyridíny, farmaceutický prostriedok s ich obsahom a ich použitie

Also Published As

Publication number Publication date
JP2000513018A (ja) 2000-10-03
AU729730B2 (en) 2001-02-08
SK143699A3 (en) 2000-07-11
WO1998047871A1 (en) 1998-10-29
CN1182117C (zh) 2004-12-29
HUP0003155A3 (en) 2002-01-28
CA2287482C (en) 2004-02-17
ES2223128T3 (es) 2005-02-16
AU7257198A (en) 1998-11-13
HU226999B1 (en) 2010-04-28
YU53699A (sh) 2001-12-26
BR9808923B1 (pt) 2010-08-24
EA199900948A1 (ru) 2000-04-24
CA2287482A1 (en) 1998-10-29
HUP0003155A2 (hu) 2001-06-28
DE69824839T2 (de) 2005-07-07
HK1023771A1 (en) 2000-09-22
UA66792C2 (uk) 2004-06-15
KR20010006546A (ko) 2001-01-26
HRP980206B1 (en) 2002-02-28
EA002190B1 (ru) 2002-02-28
PL336298A1 (en) 2000-06-19
EP0975596B1 (en) 2004-06-30
DE69824839D1 (de) 2004-08-05
JP3300369B2 (ja) 2002-07-08
ATE270275T1 (de) 2004-07-15
CZ369099A3 (cs) 2000-04-12
CZ293246B6 (cs) 2004-03-17
BR9808923A (pt) 2000-08-01
HRP980206A2 (en) 1998-12-31
NZ500390A (en) 2001-08-31
TW492959B (en) 2002-07-01
PL190265B1 (pl) 2005-11-30
CN1260782A (zh) 2000-07-19
SK285037B6 (sk) 2006-05-04
EP0975596A1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
RS49881B (sr) Supstituisani piridini kao selektivni inhibitori ciklooksigenaze-2
RS49901B (sr) Postupak za dobijanje 2-aril-3-aril-5-halogeno piridina korisnih kao cox-2 inhibitori
YU47288B (sh) Akrilatni fungicidi i postupak za njihovo dobijanje
GB1312536A (en) Hydantoin derivatives
EP0077938A3 (en) N-(3-substituted aminophenyl) tetrahydrophthalimides and herbicidal composition
RS50672B (sr) Postupak za pripremanje n-fenilpirazol-1-karboksamida
DK1117297T3 (da) Syntetiske analoger af ecteinascidin-743
RS51085B (sr) Derivati dioksan-2-alkilkarbamata, postupak za njihovo dobijanje i primena istih u terapeuticima
ES2179817T3 (es) Dispersantes de pigmento y composicion de pigmentos que los contienen.
ES2137512T3 (es) Derivados de amidina biciclicos como inhibidores de la sintetasa de oxido nitrico.
DE3474022D1 (de) Quinazoline and isoquinoline derivatives
HUP0000524A2 (hu) Eljárás tiazolszármazékok és intermedierjeik előállítására
EP0273349A3 (en) Resolution of 1,4-dihydropyridine derivatives
EA199901096A1 (ru) Цианогуанидины в качестве ингибиторов пролиферации клеток
HRP20000878B1 (en) Chemical synthesis of morpholine derivatives
EP0174131A3 (en) Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
DK0968189T3 (da) Fremgangsmåde til fremstilling af nicotinsyrer
KR840005107A (ko) 피리미디온 및 그의 산부가염의 제조방법
DK1854800T3 (da) Tumorhæmmende derivater af ecteinascidin ET-743
GB959203A (en) Indole derivatives and salts thereof
GB1392681A (en) Process for the mahufacture of benzodiazepine derivatives
HUP0300179A2 (en) Process for the preparation of 6-(perfluoroalkyl)uracil compounds
KR840000480A (ko) 페녹시 벤조산류에서 유도된 제초제 화합물류의 제조방법
AR009870A1 (es) Proceso para hacer compuestos derivados de piridina 2-aril-3-aril-5-sustituidos que son utiles como inhibidores de cox-2 .
SE8604147D0 (sv) Herbicidal 4-chloro-aryloxi-acetyl- and 4-chloro-aryloxy-propionyl-malonates